Curiteva announces commercialization of its Prowess Laminoplasty system
Curiteva, a privately held technology and manufacturing company based in Huntsville, Alabama, is proud to announce the commercial launch of its Prowess Laminoplasty System. The system is designed to provide surgeons with the tools they need to perform posterior decompression of the cervical spine with greater precision, accuracy and efficiency.
The Prowess system was designed based on feedback from surgeons and the first cases were performed by Dr. Joel Pickett at Huntsville Hospital in Huntsville, AL. “I am very pleased with the comprehensive, easy-to-use design of this system,” said Dr. Pickett. “This system is just a representation of Curiteva’s vision to maximize results while minimizing patient impact.”
The system consists of a variety of plate and spacer options, making it intraoperatively adjustable to treat different patient anatomies. The easy-to-use kit layout features streamlined tools such as a self-locking screwdriver, multiple plate insertion options and screw hole preparation choices, ensuring a consistent approach to the laminoplasty procedure.
“The feedback from distributors, scrub techs and surgeons has been overwhelmingly positive. They consistently tell us that our system is both reliable and efficient,” said Kevin Dill, director of strategic initiatives at Curiteva.
Curiteva strives to provide innovative solutions to improve patient outcomes. As the system grows, Curiteva plans to integrate the Inspire 3D printed trabecular PEEK technology into the laminoplasty spacer as an alternative to allograft.
About Curiteva:
Curiteva is a privately held technology and manufacturing company based in Huntsville, AL. Our company is founded on a commitment to building world-class manufacturing, accelerating research and development, maintaining lean operational discipline, and delivering new technology to meet the evolving needs of our customers and the patients they serve. operate. Curiteva is pioneering 3D printing of trabecular PEEK implants with a bioactive nanosurface to revolutionize how engineered structures and implant biomaterials accelerate immunomodulation, enhance healing and improve patient outcomes . For more information, please visit www.curiteva.com
